ENFN - Enfusion GAAP EPS of -$0.10 misses by $0.03 revenue of $34.14M beats by $1.1M
Enfusion press release (NYSE:ENFN): Q1 GAAP EPS of -$0.10 misses by $0.03. Revenue of $34.14M (+40.2% Y/Y) beats by $1.1M. Second Quarter 2022 Outlook: Total revenue is expected to be in the range of $35 million to $36 million vs. $35.50M consensus. Adjusted EBITDA is expected to be in the range of $4 million to $4.5 million. Full Year 2022 Outlook: Total revenue is expected to be in the range of $148.1 million to $151.1 million vs. $148.47M consensus. Adjusted EBITDA is expected to be in the range of $17.2 million to $19.2 million.
For further details see:
Enfusion GAAP EPS of -$0.10 misses by $0.03, revenue of $34.14M beats by $1.1M